Psychemedics announces the launch of the Advanced 5-Panel Drug Screen. The company said, “This offering will transform the way organizations safeguard their workplaces, shifting the spotlight from marijuana to the paramount threat of fentanyl. Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is a leap forward in drug screening technology.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PMD:
- Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
- Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
- Psychemedics appoints Shannon Shoemaker as Chief Revenue Officer
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue